← FDA Warning Letters

LXR Biotech, LLC

FDA Warning Letter · 2023-08-01 · Division of Pharmaceutical Quality Operations III

Letter

Company
LXR Biotech, LLC
Posted Date
2023-08-01
Letter Issue Date
2023-07-17
Issuing Office
Division of Pharmaceutical Quality Operations III

Subject

CGMP/Finished Pharmaceuticals/Adulterated

Source

Authoritative
FDA Warning Letters
Machine
JSON-LD · Markdown